AUSTIN, Texas, Aug. 9 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN) announced today that the Company and the FDA have reached agreement to ...
AUSTIN, Texas--(BUSINESS WIRE)--Dec. 3, 2008--As part of its ongoing restructuring, Introgen Therapeutics, Inc. (NASDAQ:INGN), today announced that the company has elected to file Chapter 11 petitions ...
Houston and Austin, TX, October 25, 2001- Introgen Therapeutics, Inc. (NASDAQ: INGN) announced today that results of preclinical studies in melanoma have been published in the October 2001 issue of ...
Introgen Therapeutics, Inc. has announced that a patent has been awarded by the U.S. Patent and Trademark Office which covers, for example, administration of chemotherapeutic drugs, radiation ...
With a lack of products, Introgen's burn rate is a key factor for investors to figure out its chance of survival. You'd think that after more than a decade of research, a company without any products ...
Chief Executive Officer, Other Senior Executive Officers, Resign in Connection with Cost Cutting Move AUSTIN, Texas, Nov 26, 2008 (BUSINESS WIRE) -- Introgen Therapeutics, Inc. (NASDAQ:INGN), today ...
Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today its financial results for the quarter and year ended December 31, 2006. The results were consistent with the Company’s expectations and a ...
A reduction in operating expenses helped Introgen Therapeutics Inc. lower its second quarter loss, but the biopharmaceutical company is still facing concerns over the effectiveness of its flagship ...
Introgen Therapeutics, Inc. has announced that it has obtained a worldwide, exclusive license to a family of patent applications directed to combination therapy using ADVEXIN ® with inhibitors of ...
AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today that it will host a conference call with management and invited clinical experts on Thursday, July 10, 2008 at ...
Introgen Therapeutics Inc., an Austin-based drug development company, has filed to issue up to $150 million worth of stock with the Securities and Exchange Commission. Introgen (NASDAQ: INGN) says it ...
If you look on the fifth page of Gov. Rick Perry’s personal financial disclosure form on file at the Texas Ethics Commission, the first investment listed is for his son Griffin’s trust fund. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results